Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China

Abstract We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuli Qu, Xuedan You, Tianyi Liu, Lijiao Wang, Zheng Yin, Yanjun Liu, Chong Ye, Ting Yang, Mao Huang, Hongchao Li, Liwen Fang, Jinping Zheng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/d66cc3a31b824327a14d26d81d7ffa8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d66cc3a31b824327a14d26d81d7ffa8f
record_format dspace
spelling oai:doaj.org-article:d66cc3a31b824327a14d26d81d7ffa8f2021-12-02T14:59:05ZCost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China10.1038/s41533-021-00233-z2055-1010https://doaj.org/article/d66cc3a31b824327a14d26d81d7ffa8f2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41533-021-00233-zhttps://doaj.org/toc/2055-1010Abstract We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of −5026 and −1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China.Shuli QuXuedan YouTianyi LiuLijiao WangZheng YinYanjun LiuChong YeTing YangMao HuangHongchao LiLiwen FangJinping ZhengNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the respiratory system
RC705-779
spellingShingle Diseases of the respiratory system
RC705-779
Shuli Qu
Xuedan You
Tianyi Liu
Lijiao Wang
Zheng Yin
Yanjun Liu
Chong Ye
Ting Yang
Mao Huang
Hongchao Li
Liwen Fang
Jinping Zheng
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
description Abstract We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of −5026 and −1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China.
format article
author Shuli Qu
Xuedan You
Tianyi Liu
Lijiao Wang
Zheng Yin
Yanjun Liu
Chong Ye
Ting Yang
Mao Huang
Hongchao Li
Liwen Fang
Jinping Zheng
author_facet Shuli Qu
Xuedan You
Tianyi Liu
Lijiao Wang
Zheng Yin
Yanjun Liu
Chong Ye
Ting Yang
Mao Huang
Hongchao Li
Liwen Fang
Jinping Zheng
author_sort Shuli Qu
title Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_short Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_full Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_fullStr Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_full_unstemmed Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_sort cost-effectiveness analysis of copd screening programs in primary care for high-risk patients in china
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d66cc3a31b824327a14d26d81d7ffa8f
work_keys_str_mv AT shuliqu costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT xuedanyou costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT tianyiliu costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT lijiaowang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT zhengyin costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT yanjunliu costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT chongye costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT tingyang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT maohuang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT hongchaoli costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT liwenfang costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT jinpingzheng costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
_version_ 1718389231653486592